This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

StemCells, Inc. CEO Discusses Interim 6-Month Data From Spinal Cord Injury Trial - Call Transcript

Stocks in this article: STEM

In that regard we examine the patients clinically for a number of sensory modalities in the thoracic area which include light touch, pinprick pain, and temperature sensation. We’re also doing tests to examine electrical impulse transmission in the spinal cord across the level of injury and this refers to what is known as somatosensory evoked potentials or SSEPs as well as electrical heat potentials, different sensory stimuli if you will that are then recorded to determine whether any electrical current across the level of injury. And then of course, MRI imaging as well.

The summary today that we’ll be providing you with in more detail that Dr. Curt will go through has given us so far a very favorable safety profile. At this point with the six month interim data we have no adverse events that are related to the cells and there’s no evidence of any change in the pain threshold or sensation for the patients in terms of adverse concerns. Also, the surgery immunosuppression have been well tolerated in all three patients.

As we have examined these patients over time at both the three and six month intervals, Dr. Curt and his team have observed considerable gains in sensory function in two of the three subjects. The third subject remains stable. What we have seen is changes in sensory modalities over more than one time of sensation and we see these in multiple segments below the level of injury. We’ve also been able to look at these sensory changes in a quantitative way as well as looking at electrophysiology and this is again, details that Dr. Curt will go into. But both the quantitative and electrophysiology are helping confirm the clinical examination changes that we are seeing for sensations in these two patients. So in general what we have seen no win this interim analysis is progressive and consistent changes in sensory function over more than one level in both of these patients and give what we understand to be the history of spinal cord injury recovery we think that these changes are unanticipated and we’ll show you some data from the European network that speaks to this in detail.

Read the rest of this transcript for free on seekingalpha.com

3 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs